Navigation Links
Dose optimization workshop helps reduce radiation dose associated with MDCT scans
Date:8/1/2010

Numerous radiology practices were able to significantly reduce the radiation dose associated with multi-detector computed tomography (MDCT) scans by participating in a one day dose optimization workshop provided by the Royal Australian and New Zealand College of Radiologists (RANZCR) and supported by the local state health department, according to a study in the August issue of the Journal of the American College of Radiology (www.jacr.org).

Ten hospital-based public and private sector radiology practices in Queensland, Australia, participated in the study. A one day feedback and optimization training workshop was conducted for participating practices and was attended by the radiologist and medical imaging technologist responsible for the project at each site.

Data from 1,208 scans performed prior to the workshop was compared to data from 1,153 scans performed after the workshop. Results showed that after the workshop the average dose reduction for adult MDCT scans of the brain was 46 percent; for adult MDCT pulmonary angiograms was 28 percent; for adult MDCT lumbar spine scans was 29 percent; and for adult MDCT urograms was 24 percent.

"Although recent advances in CT technology may offer dose savings without the need to undertake an optimization process, recent work indicates that optimization is still required to deliver maximum dose savings while maintaining diagnostic image quality," said Anthony Wallace, medical physicist and lead author of the study.

"Our study shows that small group teaching about optimization enabled clinically meaningful dose reduction for a variety of common adult scans. However, access to medical radiation physicists, assistance with time consuming data collection, and technical support from a medical imaging technologist, were critical to the success of the program," said Wallace.


'/>"/>

Contact: Heather Curry
hcurry@acr-arrs.org
703-390-9822
American College of Radiology / American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. DiagnoCure announces optimization of entreprise structure
2. Small Business Social Media Optimization Service
3. Recession Buster for Small Businesses: Website Design and Search Engine Optimization on a Shoestring
4. VKernel Raises Scalability and Reporting Bar with Optimization Pack 1.4
5. KPA and TK Carsites offer HR, OSHA and Internet Marketing Workshops at the NADA Convention and Expo 2010
6. Learn to Dance in a Day -- Beginner Workshop Launches Modern Jive in Toronto
7. Carnegie Mellon to host workshop about basics of technology entrepreneurship
8. Rutgers University Offers Fundamentals of Finance and Accounting Workshop at Mount Laurel, New Jersey Location Aimed at Non-Financial Managers
9. Carnegie Mellon to host crisis management workshop
10. FDA, SNM and RSNA host April 13-14 two-topic imaging workshop
11. Free CME/CE Lecture and Workshop on Multiple Sclerosis: Boise, ID
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Cheap Hosting USA is among the most distinguished review ... that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) is the best cheap ... , “iPower is one of the most reliable hosting ... of useful products for new and old clients. What’s ... and a number of features which will appeal to ...
(Date:10/22/2014)... Losing Weight Your Body’s Way , In ... in the face, it certainly can be difficult to choose ... an extra favor by doing it the healthy way? Set ... listen to your body, exercise regularly, and choose foods with ... losing weight; you need to exercise more and eat less. ...
(Date:10/22/2014)... CA (PRWEB) October 22, 2014 Lintelus, ... Cormier, Sr. Vice President of Sales, will be speaking ... upcoming Meetings Technology Expo on October 28, at the ... be hosting a booth as well as a Tech ... Lintelus Meeting can create a more engaging event experience. ...
(Date:10/22/2014)... MA (PRWEB) October 22, 2014 ... new solutions for the treatment of bacterial infections, microbial ... Sinskey has joined its board of directors. , ... and Engineering Systems at The Massachusetts Institute of Technology, ... MIT faculty since 1968. Dr. Sinskey also holds positions ...
(Date:10/22/2014)... Maureen Salamon HealthDay ... Black women undergoing in vitro fertilization (IVF) are only about ... the popular assisted reproduction technique, new research indicates, and the ... In the study, about 31 percent of white patients became ... patients. Analyzing more than 4,000 IVF cycles over two ...
Breaking Medicine News(10 mins):Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3
... Are Ignoring the Fight Against Cancer, CLEVELAND, ... took the stage for a final debate before ... matters important to the,American public but fell short ... cancer is an issue identified by 62 percent ...
... Clinton Defends Healthcare Plan Built on Extending Customers and ... Revenue of Private Insurance ... Moore,participated in a press conference call today organized by ... from the movie SiCKO, including Reggie Cervantes, a,9/11 rescue ...
... Aflac Incorporated,(NYSE: AFL ) announced today that ... 29th Annual Institutional Investors Conference. President and Chief,Financial ... he is scheduled to make a presentation on ... Incorporated presentation, Mr. Cloninger will discuss the,company,s outlook ...
... of the worlds pre-eminent experts in urogynecology at Oregon Health ... the National Institutes of Health to study the extent of ... , The pelvic floor comprises the muscle group that ... injury, which is caused by damage to pelvic muscles or ...
... Citing a Center for,Medicare and Medicaid Services (CMS) ... 20 percent of national health care spending by,2017, ... statement,urging the House to take up legislation introduced ... (D-Md.) to safeguard Medicare:, "Looking at this ...
... -- Millions of cancer patients take drugs to boost ... anemic after chemotherapy. But a new study by Northwestern ... erythropoiesis-stimulating agents (ESAs), actually raise patients, risk of death, ... , A meta-analysis of 51 trials with 13,613 patients ...
Cached Medicine News:Health News:Democratic Candidates Miss Key Health Issue in Debate 2Health News:Michael Moore Defends 9/11 Rescue Workers and Criticizes Insurance Industry on California Nurses Association Press Call 2Health News:Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference 2Health News:NIH awards OHSU researcher $1.2 million to determine causes of, risk factors for pelvic floor injury 2Health News:Blunt Cites New CMS Report in Calling for Action on Safeguarding Medicare 2Health News:Drug for anemic cancer patients raises risk of death 2Health News:Drug for anemic cancer patients raises risk of death 3
(Date:10/22/2014)... , Oct. 22, 2014  Regulus ... a biopharmaceutical company leading the discovery and ... announced that it has demonstrated human proof-of-concept ... clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated ... of hepatitis C virus infection ("HCV").  Interim ...
(Date:10/20/2014)... 2014  Indianapolis interventional medical device maker ... -based 3D visualization leader Synaptive Medical ... Annual Meeting that they have joined forces to ... collaboration is the first of its kind and ... outcomes. NICO,s BrainPath® interventional access technology and Synaptive,s ...
(Date:10/20/2014)...   BioNano Genomics announced today achievement of a ... human data at 30X depth, sufficient for a genome map, ... was established and demonstrated for the IrysChip TM V2, ... and will be rolled out to BioNano,s collaborators and ... this advancement at the American Society for Human Genetics ...
Breaking Medicine Technology:A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5BioNano Genomics Announces One Human : One Chip : One Day 2BioNano Genomics Announces One Human : One Chip : One Day 3
... Calif., Oct. 19 NovaBay Pharmaceuticals , ... non-antibiotic anti-infective compounds for the treatment or prevention of a ... that the company has named Mark Anderson, Ph.D. as chief ... , "We are adding Mark to our team at a ...
... Sanofi-aventis U.S. announced that the U.S. Food and ... (rasburicase) to be used for the initial management of ... leukemia, lymphoma, and solid tumor malignancies who are receiving ... (TLS) and subsequent elevations of plasma uric acid. ...
Cached Medicine Technology:NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer 2NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer 3FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy 2FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy 3FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy 4FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy 5FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy 6FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy 7
Platelet Aggregation Profiler...
... combines proven Eclipse,Plus or 850 ... and retrieval capability. Doctors,maintain all ... ECG device and gain the,ability ... tracings from personal computers., With ...
... Vision5L Digital Holter ... or 7-lead, 3-channel,Holter ... signal preview,screen. Fast ... a compact,flash card ...
... face provides three contrast levels (high, 9.5 % ... 20/100. This test is designed to detect very ... contact lens evaluation or due to refractive surgery. ... the same contrast and acuity levels as the ...
Medicine Products: